A genome-wide analysis of human IBD samples (both CD and ulcerative colitis [UC]) shows reduced expression of guanylin and GC-C in diseased tissues with active inflammation, implying that GC-C plays a role in this disease [187]. Here, GUCY2C is linked to inflammatory bowel disease.